THE WHAT?   Beiersdorf, the Hamburg-based skincare giant, has announced a significant breakthrough in anti-aging research with the introduction of ‘Glycostop™’, a patented active ingredient designed to combat glycation, a process that accelerates skin aging due to sugar. This innovation marks the culmination of a decade’s research involving the testing of approximately 1,700 substances.

THE DETAILS    Glycation, a natural but harmful chemical reaction where sugar molecules bond with proteins, notably diminishes skin elasticity and resilience, leading to wrinkles and a yellowish discoloration. Beiersdorf’s new ingredient, NAHP (N-Acetyl-L-hydroxyproline), effectively prevents the formation of harmful glycation end-products (AGEs) by up to 68%, safeguarding the skin’s collagen and elastin fibers. The breakthrough was led by Dr. Gitta Neufang and her team of over 1,000 researchers, building on Beiersdorf’s legacy of anti-aging innovations such as the coenzyme Q10.

THE WHY? This groundbreaking development not only enhances Beiersdorf’s portfolio in the anti-aging market but also sets new standards in skincare technology. The introduction of the NIVEA Q10 Dual Action Serum in April 2024, which combines ‘Glycostop™’ with Q10, offers consumers a powerful dual-action formula that tackles wrinkles and skin ageing from its roots. This product aligns with the company’s commitment to sustainability, featuring eco-friendly packaging and a formulation free from harmful additives.